Joel Greenblatt Dexcom Inc Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Dexcom Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 78,799 shares of DXCM stock, worth $5.98 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

78,799

Previous 47,880 64.58%

Holding current value

$5.98 Million

Previous $5.43 Million 2.71%

% of portfolio

0.06%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $1.98 Million - $3.59 Million	30,919 Added 64.58%	78,799 $5.28 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $912,925 - $1.16 Million	8,276 Added 20.9%	47,880 $5.43 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $19,188 - $23,536	-168 Reduced 0.42%	39,604 $5.49 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $3.02 Million - $4.97 Million	-40,027 Reduced 50.16%	39,772 $4.94 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $4.03 Million - $6.47 Million	46,879 Added 142.4%	79,799 $7.45 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $1.36 Million - $1.58 Million	-12,090 Reduced 26.86%	32,920 $4.23 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $5.02 Million - $5.94 Million	-48,296 Reduced 51.76%	45,010 $5.23 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $4.69 Million - $6.77 Million	55,181 Added 144.74%	93,306 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $1.44 Million - $1.78 Million	18,855 Added 97.85%	38,125 $3.07 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $807,789 - $1.58 Million	11,881 Added 160.79%	19,270 $1.44 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $254,110 - $351,670	2,701 Added 57.62%	7,389 $3.78 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $516,363 - $647,372	3,976 Added 558.43%	4,688 $2.52 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $75,977 - $101,944	712 New	712 $389,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $147,195 - $181,828	-1,736 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $76,830 - $102,932	-985 Reduced 36.2%	1,736 $642,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $94,172 - $111,368	986 Added 56.83%	2,721 $1.12 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $1.57 Million - $2.64 Million	-25,077 Reduced 93.53%	1,735 $703,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.08 Million - $1.72 Million	22,700 Added 552.04%	26,812 $7.22 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $150,581 - $235,576	4,112 New	4,112 $899,000
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $176,101 - $253,208	-10,040 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $131,122 - $186,141	10,040 New	10,040 $745,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account